BT
Barry Ticho (CHIEF MEDICAL OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $308K of STOK (9,677 sh across 2 lots, as filed), executed Mar 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.1M
shares × price, as filed
Last traded
Nov 2
Filed Nov 4
Median ADV $25.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
STOKRecent filings
STOKSALE
Stoke Therapeutics, Inc.
View filing →
$229K22,790 sh × $10.03
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $178K
13,945 sh × $12.78
Exec Dec 6 2024
Filed Dec 10 2024 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $121K
10,000 sh × $12.07
Exec Dec 2 2024
Filed Dec 3 2024 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $127K
10,000 sh × $12.68
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET